The activated phagocyte of polycythemia vera.
نویسندگان
چکیده
Leukocytes isolated from patients with polycythemia vera (PCV), a panmyelopathy, have increased metabolic activity during the resting and phagocytizing states. Phagocytes from patients with PCV were studied by counting particle ingestion, measuring hexose monophosphate shunt (HMP) activity by the conversion of glucose1-’4C tr, ‘4CO2, and determining 02 consumption and nitroblue tetrazolium (NBT) reduction. Phagocytosis of polystyrene particles was increased. Resting glucose-1-’4C activity was 6.9 ± 2.7 nmoles of glucose oxidized per hour per 5 X 106 phagocytes in normal and 16.4 ± 7.6 nmoles in polycythemia vera phagocytes. Hexose monophosphate shunt following phagocytosis increased to 50.6 ± 10.4 nmoles in normal and 91.7 ± 17.0 in polycythemia vera phagocytes (p < 0.005). Oxygen consumption was 3.6 ± 0.2 I/hr/5 X 106 phagocytes in resting and 11.4 i l/hr/5 X 106 phagocytes in stimulated controls as compared to 4.8 ± 0.2 I in resting and 18.4 i I in phagocytizing PCV cells (p <0.001). The reduction of NBT by leukocytes was increased in all resting polycythemia vera phagocytes as compared to control phagocytes. The cells from some patients had increases in the amount of NBT reduced during phagocytosis. Phagocytes from four severly infected patients had increases in HMP activity in both resting and phagocytizing cells similar to those found in noninfected PCV phagocytes. Although the increased metabolic activity associated with phagocytosis can be explained by increased particle ingestion. the increased activity of resting PCV cells suggests other metabolic abnormalities perhaps related to the age of the phagocyte.
منابع مشابه
Complex Arterial and Venous Thrombosis in Polycythemia Vera: what Does Leukocytosis Predict?
Thromboembolic events represent the main cause of morbidity and mortality in patients with polycythemia vera. Leukocytosis has been identified as an important risk factor for development of vascular thrombosis. A 47-year-old woman with polycythemia vera presented with pain and swelling in her right calf. She was scheduled to receive anagrelide which was effective on polycythemia and thrombocyto...
متن کاملA Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques
Objective(s): Functional imaging presents a non-invasive process that may capture the hyper-metabolic nature of red bone marrow in myeloproliferative neoplasms, such as polycythemia vera (PV). Methods: This study analyzed the FDG-PET/CT scans (n=12) of six patients diagnosed with PV and six age-sex matched controls using a quantitative global analysis methodol...
متن کاملTransient Spinal Cord Ischemia as Presenting Manifestation of Polycythemia Vera
Spinal arterial vascularization is supplied by a large anastomotic net, making spinal ischemic events far less common than ischemic cerebral strokes. Polycythemia vera, due to blood hyperviscosity and activated platelet aggregation, is associated with a higher risk of arterial and venous thrombotic events. We report a patient with spinal cord transient ischemic attacks, a rarely presenting mani...
متن کاملFrom leeches to personalized medicine: evolving concepts in the management of polycythemia vera.
Polycythemia vera is a clonal disorder of hematopoietic stem/progenitor cells. It manifests as an expansion of red cell mass. It is the most common chronic myeloproliferative neoplasm. In virtually all cases, it is characterized by a V617F point mutation in JAK2 exon 14 or less common mutations in exon 12. The landmark discovery of the autonomously activated JAK/STAT signaling pathway paved the...
متن کاملارزیابی میزان جهش JAK2V617F در بیماران میلو پرولیفراتیو مزمن به روش AS-RT-PCR
Background and Aim: The JAK2 is an acquired mutation that is observed in majority of patients with classical Philadelphia-negative Myeloproliferative neoplasms that include polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF). This acquired mutation is characterized by a G to T transversion at nucleotide 1849 in exon 12 of the JAK2 gene, leading to a substitution ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood
دوره 40 3 شماره
صفحات -
تاریخ انتشار 1972